These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors. Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512 [TBL] [Abstract][Full Text] [Related]
3. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5. Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820 [TBL] [Abstract][Full Text] [Related]
4. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696 [TBL] [Abstract][Full Text] [Related]
5. Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain. Boinon L; Yu J; Madura CL; Chefdeville A; Feinstein DL; Moutal A; Khanna R Pain; 2022 Feb; 163(2):e368-e381. PubMed ID: 35029600 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain. François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471 [TBL] [Abstract][Full Text] [Related]
7. Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. Moutal A; Luo S; Largent-Milnes TM; Vanderah TW; Khanna R Neurobiol Pain; 2019; 5():. PubMed ID: 31080913 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury. Moutal A; Ji Y; Bellampalli SS; Khanna R Mol Brain; 2020 Jun; 13(1):97. PubMed ID: 32571373 [TBL] [Abstract][Full Text] [Related]
9. CRMP2-Neurofibromin Interface Drives NF1-related Pain. Moutal A; Sun L; Yang X; Li W; Cai S; Luo S; Khanna R Neuroscience; 2018 Jun; 381():79-90. PubMed ID: 29655575 [TBL] [Abstract][Full Text] [Related]
10. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels. Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467 [TBL] [Abstract][Full Text] [Related]
11. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking. Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888 [TBL] [Abstract][Full Text] [Related]
12. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels. François-Moutal L; Scott DD; Perez-Miller S; Gokhale V; Khanna M; Khanna R Channels (Austin); 2018; 12(1):219-227. PubMed ID: 30081699 [TBL] [Abstract][Full Text] [Related]
13. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons. Cai S; Shan Z; Zhang Z; Moutal A; Khanna R Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580 [TBL] [Abstract][Full Text] [Related]